Biomimetic nanomedicines for precise atherosclerosis theranostics

被引：8
|
作者：
Tao, Ying [1 ,2 ]
Lan, Xinmiao [3 ]
Zhang, Yang [4 ,5 ]
Fu, Chenxing [6 ,7 ]
Liu, Lu [8 ]
Cao, Feng [4 ,5 ]
Guo, Weisheng [1 ,2 ]
机构：
[1] Guangzhou Med Univ, Dept Minimally Invas Intervent Radiol, Key Lab Mol Target & Clin Pharmacol, Sch Biomed Engn, Guangzhou 510260, Peoples R China
[2] Guangzhou Med Univ, Affiliated Hosp 2, Guangzhou 510260, Peoples R China
[3] Capital Med Univ, Sch Pharmaceut Sci, Beijing 100069, Peoples R China
[4] Chinese Peoples Liberat Army Gen Hosp, Med Ctr 2, Dept Cardiol, Beijing 100853, Peoples R China
[5] Chinese Peoples Liberat Army Gen Hosp, Natl Clin Res Ctr Geriatr Dis, Beijing 100853, Peoples R China
[6] Southern Med Univ, Zhujiang Hosp, Dept Cardiol, Guangzhou 510280, Peoples R China
[7] Southern Med Univ, Zhujiang Hosp, Lab Heart Ctr, Guangzhou 510280, Peoples R China
[8] Univ Hong Kong, Li Ka Shing Fac Med, Dept Pharmacol & Pharm, Hong Kong 999077, Peoples R China
来源：
ACTA PHARMACEUTICA SINICA B | 2023年 / 13卷 / 11期
基金：
中国国家自然科学基金;
关键词：
Nanotheranostics; Atherosclerosis; Biomimetic nanomedicines; Drug delivery; Passive targeting; Active targeting; Plaques; Diagnosis and treatment; DRUG-DELIVERY; EXTRACELLULAR VESICLES; IN-VIVO; MEDIATED DELIVERY; TARGETED DELIVERY; MOUSE MODEL; NANOPARTICLES; PLAQUE; CELL; INFLAMMATION;
D O I：
10.1016/j.apsb.2022.11.014
中图分类号：
R9 [药学];
学科分类号：
1007 ;
摘要：
Atherosclerosis (AS) is a leading cause of the life-threatening cardiovascular disease (CVD), creating an urgent need for efficient, biocompatible therapeutics for diagnosis and treatment. Biomimetic nanomedicines (bNMs) are moving closer to fulfilling this need, pushing back the frontier of nano-based drug delivery systems design. This review seeks to outline how these nanomedicines (NMs) might work to diagnose and treat atherosclerosis, to trace the trajectory of their development to date and in the coming years, and to provide a foundation for further discussion about atherosclerotic theranostics.(c) 2023 Chinese Pharmaceutical Association and Institute of Materia Medica, Chinese Academy of Medical Sciences. Production and hosting by Elsevier B.V. This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).
引用
收藏
页码：4442 / 4460
页数：19
相关论文
共 50 条
  • [31] Hypoxia-responsive AIEgens for precise disease theranostics
    Liu, Dongfang
    Liang, Mengyun
    Fan, Aohua
    Bing, Wei
    Qi, Ji
    [J]. LUMINESCENCE, 2024, 39 (01)
  • [32] Cell membrane camouflaged biomimetic nanoparticles: Focusing on tumor theranostics
    Zhu, Li
    Zhong, Yuan
    Wu, Shuai
    Yan, Meng
    Cao, Yu
    Mou, Nianlian
    Wang, Guixue
    Sun, Da
    Wu, Wei
    [J]. MATERIALS TODAY BIO, 2022, 14
  • [33] UCNP-based Photoluminescent Nanomedicines for Theranostics of HER2-positive tumors
    Guryev, Evgenii L.
    Bausheva, Daria K.
    Shilyagina, Natalia Y.
    Balalaeva, Irina V.
    Deyev, Sergey M.
    Zvyagin, Andrei V.
    [J]. CELL DEATH DISCOVERY, 2022, 8 : 8 - 9
  • [34] Near Infrared Light-Activatable Platelet-Mimicking NIR-II NO Nano-Prodrug for Precise Atherosclerosis Theranostics
    Chai, Yun
    Shangguan, Lina
    Yu, Hui
    Sun, Ye
    Huang, Xiaoyan
    Zhu, Yanyan
    Wang, Hai-Yan
    Liu, Yi
    [J]. ADVANCED SCIENCE, 2024, 11 (03)
  • [35] Biomimetic Cell Membrane-Coated Nanoparticles for Cancer Theranostics
    Jiang, Tiantian
    Zhan, Yiduo
    Ding, Jiayao
    Song, Zheming
    Zhang, Yijing
    Li, Jingchao
    Su, Ting
    [J]. CHEMMEDCHEM, 2024,
  • [36] Recent advances in curcumin-loaded biomimetic nanomedicines for targeted therapies
    Lei, Fenting
    Li, Pei
    Chen, Tangting
    Wang, Qian
    Wang, Chenglong
    Liu, Yan
    Deng, Yiping
    Zhang, Zongquan
    Xu, Maochang
    Tian, Ji
    Ren, Wei
    Li, Chunhong
    [J]. JOURNAL OF DRUG DELIVERY SCIENCE AND TECHNOLOGY, 2023, 80
  • [37] Combating atherosclerosis with targeted nanomedicines: recent advances and future prospective
    Nakhlband, Ailar
    Eskandani, Morteza
    Omidi, Yadollah
    Saeedi, Nazli
    Ghaffari, Samad
    Barar, Jaleh
    Garjani, Alireza
    [J]. BIOIMPACTS, 2018, 8 (01) : 59 - 75
  • [38] Recent progress in therapeutic strategies and biomimetic nanomedicines for rheumatoid arthritis treatment
    Li, Chunhong
    Zheng, Xiu
    Hu, Mei
    Jia, Ming
    Jin, Rongrong
    Nie, Yu
    [J]. EXPERT OPINION ON DRUG DELIVERY, 2022, 19 (08) : 883 - 898
  • [39] Biomimetic Nanoparticles for the Diagnosis and Therapy of Atherosclerosis
    Wang, Yan
    Li, Yize
    Lu, Yuqing
    Li, Jingjing
    [J]. CHEMICAL RECORD, 2024, 24 (09):
  • [40] Cell Membrane Coated-Biomimetic Nanoplatforms Toward Cancer Theranostics
    Li, Tingting
    Qin, Xiang
    Li, Yichao
    Shen, Xue
    Li, Shun
    Yang, Hong
    Wu, Chunhui
    Zheng, Chuan
    Zhu, Jie
    You, Fengming
    Liu, Yiyao
    [J]. FRONTIERS IN BIOENGINEERING AND BIOTECHNOLOGY, 2020, 8 (08)
12345